124 related articles for article (PubMed ID: 7956011)
1. In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa.
Laverdière M; Gallimore B; Restieri C; Poonia K; Chow AW
Diagn Microbiol Infect Dis; 1994 May; 19(1):39-46. PubMed ID: 7956011
[TBL] [Abstract][Full Text] [Related]
2. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
Plasencia V; Borrell N; Maciá MD; Moya B; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2007 Jul; 51(7):2574-81. PubMed ID: 17470655
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
4. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Chan EL; Zabransky RJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):157-64. PubMed ID: 3102156
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
Piccoli L; Guerrini M; Felici A; Marchetti F
J Chemother; 2005 Aug; 17(4):355-60. PubMed ID: 16167512
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Mayer I; Nagy E
J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
[TBL] [Abstract][Full Text] [Related]
7. Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosa.
Madaras-Kelly KJ; Moody J; Larsson A; Baeker Hovde L; Rotschafer JC
Chemotherapy; 1997; 43(2):108-17. PubMed ID: 9084919
[TBL] [Abstract][Full Text] [Related]
8. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
[TBL] [Abstract][Full Text] [Related]
10. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Yamashiro Y; Ogake N; Takahata M; Minami S
Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Angehrn P
Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424
[TBL] [Abstract][Full Text] [Related]
13. Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Bilal H; Tait JR; Lang Y; Zhou J; Bergen PJ; Peleg AY; Bulitta JB; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0220321. PubMed ID: 35041509
[TBL] [Abstract][Full Text] [Related]
14. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1985 Jul; 28(1):64-8. PubMed ID: 3929682
[TBL] [Abstract][Full Text] [Related]
15. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
Kocazeybek B; Arabaci U; Erentürk S; Akdur H
Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Balke B; Hogardt M; Schmoldt S; Hoy L; Weissbrodt H; Häussler S
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):25-30. PubMed ID: 16402226
[TBL] [Abstract][Full Text] [Related]
17. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
Machka K; Dietz R
Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
[TBL] [Abstract][Full Text] [Related]
18. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa.
Moriarty F; Elborn S; Tunney M
J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142
[TBL] [Abstract][Full Text] [Related]
19. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of synergistic activity between netilmicin and tobramycin combined with ceftriaxone versus Pseudomonas and Serratia species.
Focà A; Carbone M; Mastroeni P
Chemioterapia; 1987 Jun; 6(2 Suppl):123-4. PubMed ID: 3509368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
